Plasma DNA methylation of peroxisome proliferator-activated receptor (PPAR-γ) can potentially be used to non-invasively stratify liver fibrosis severity in NAFLD (33). This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.